These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9603756)

  • 1. Economic evaluation in health: a thumb nail sketch.
    Kernick DP
    BMJ; 1998 May; 316(7145):1663-5. PubMed ID: 9603756
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling programme costs in economic evaluation.
    Fenn P; McGuire A; Backhouse M; Jones D
    J Health Econ; 1996 Feb; 15(1):115-25. PubMed ID: 10157425
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation and health care. What does it mean?
    Robinson R
    BMJ; 1993 Sep; 307(6905):670-3. PubMed ID: 8401057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic foundations of cost-effectiveness analysis.
    Garber AM; Phelps CE
    J Health Econ; 1997 Feb; 16(1):1-31. PubMed ID: 10167341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handling uncertainty in economic evaluations of healthcare interventions.
    Briggs AH; Gray AM
    BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
    [No Abstract]   [Full Text] [Related]  

  • 7. Multilevel models and health economics.
    Rice N; Jones A
    Health Econ; 1997; 6(6):561-75. PubMed ID: 9466139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of health care costs and their statistical analysis for economic evaluation (Vol 3 No 4 pp 233-245).
    Thompson S; Barber J
    J Health Serv Res Policy; 1999 Oct; 4(4):255-6. PubMed ID: 10623043
    [No Abstract]   [Full Text] [Related]  

  • 10. Care costs. Measure for measure.
    Mulholland H
    Nurs Times; 2001 Nov 15-21; 97(46):11. PubMed ID: 11966035
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodological limitations of economic evaluations of antenatal screening.
    Petrou S
    Health Econ; 2001 Dec; 10(8):775-8. PubMed ID: 11747056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unintended consequences of applying economic evaluation.
    Oliver A
    J Health Serv Res Policy; 2002 Jul; 7(3):129-30. PubMed ID: 12171741
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the NHS research and development programme: will the programme give value for money?
    Buxton M; Hanney S
    J R Soc Med; 1998; 91 Suppl 35(Suppl 35):2-6. PubMed ID: 9797742
    [No Abstract]   [Full Text] [Related]  

  • 14. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 15. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 16. The distribution of health care costs and their statistical analysis for economic evaluation.
    Briggs A; Gray A
    J Health Serv Res Policy; 1998 Oct; 3(4):233-45. PubMed ID: 10187204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creativity and sacrifice: two sides of the coin. A reply to David Seedhouse.
    Farrar S; Donaldson C; Macphee S; Walker A; Mapp T
    Health Care Anal; 1997 Dec; 5(4):306-9. PubMed ID: 10177944
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicine, money, and mathematics.
    Eddy DM
    Bull Am Coll Surg; 1992 Jun; 77(6):36-49. PubMed ID: 10118543
    [No Abstract]   [Full Text] [Related]  

  • 19. Bayesian estimation of cost-effectiveness ratios from clinical trials.
    Heitjan DF; Moskowitz AJ; Whang W
    Health Econ; 1999 May; 8(3):191-201. PubMed ID: 10348414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R&D. Failing the acid test.
    Millar B
    Health Serv J; 1998 Mar; 108(5597):24-7. PubMed ID: 10177609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.